氟米龙联合更昔洛韦治疗单疱病毒性角膜炎的效果

2017-08-26 12:29:26周光华罗平刘丞怡文志聪孙青青
中国当代医药 2017年21期

周光华++罗平+刘丞怡+文志聪+孙青青

[摘要]目的 观察氟米龙联合更昔洛韦治疗单疱病毒性角膜炎的临床效果。方法 选取2015年5月~2016年1月我院收治的68例单疱病毒性角膜炎患者作为观察对象,按照单双号法分为对照组(n=34)和研究组(n=34)。对照组给予更昔洛韦眼凝胶治疗,研究组在此基础上联合氟米龙滴眼液进行治疗,比较两组治疗效果、复发情况、治疗时间及安全性。结果 两组不良反应发生率比较,差异无统计学意义(P>0.05);研究组治疗总有效率高于对照組,差异有统计学意义(P<0.05);研究组治疗时间短于对照组,差异有统计学意义(P<0.05);研究组复发率低于对照组,差异有统计学意义(P<0.05)。结论 氟米龙联合更昔洛韦治疗单疱病毒性角膜炎效果显著,安全性高,复发率低,可有效缩短治疗时间,值得临床选择和进一步普及推广。

[关键词]单疱病毒性角膜炎;氟米龙;更昔洛韦

[中图分类号] R772.21 [文献标识码] A [文章编号] 1674-4721(2017)07(c)-0041-03

Effect of Mometasone combined with Ganciclovir on herpes simplex keratitis

ZHOU Guang-hua LUO Ping LIU Cheng-yi WEN Zhi-cong SUN Qing-qing

Department of Ophthalmology,the Fifth Affiliated Hospital of Southern Medical University,Guangdong Province,Guangzhou 510900,China

[Abstract]Objective To observe the clinical effect of Fumarillon combined with Ganciclovir in the treatment of herpes simplex keratitis.Methods 56 patients with herpes simplex keratitis were enrolled in our hospital from May 2015 to January 2016.They were divided into control group(n=34) and study group(n=34),The control group was given Ganciclovir Gel for treatment,the study group on the basis of combined with Fluoride Miron Eye Drops for treatment,compared the two groups of treatment,recurrence,treatment time and safety.Results The incidence of adverse reactions there was no significant difference between the two groups(P>0.05).The total effective rate of the study group was higher than that of the control group(P<0.05).The treatment time of the study group was shorter than that of the control group(P<0.05).The relapse rate of the study group was lower than that of the control group,the difference was statistically significant(P<0.05).Conclusion The combination of Mometrolone and Ganciclovir in the treatment of herpes simplex keratitis is effective,safe and low recurrence rate,which can effectively shorten the treatment time and deserve clinical selection and further popularization.

[Key words]Herpes simplex keratitis;Fumarillon;Ganciclovir

单疱病毒性角膜炎(HSK)是临床十分常见的疾病之一,主要是由HSV-Ⅰ(单纯疱疹病毒Ⅰ型)导致的,具体可分为原发感染与继发感染两种,前者在6个月~5岁患儿最易发病,而后者在青壮年最易发病。HSK的显著性特点为久治不愈、复发率高、治疗难度大等,该病的发病率在角膜病中占首要位置,且男性患者的患病数明显多于女性,是导致患者视力障碍甚至致盲的主要危险病因[1]。药物治疗是当前临床针对HSK的主要方法,抗病毒药物或皮质激素单独治疗的方法应用较广泛,更昔洛韦或阿昔洛韦是临床最常用的药物种类,具有理想的临床治疗效果。选取我院收治的HSK患者作为观察对象,现对治疗效果作如下总结报道。

1资料与方法

1.1一般资料

选取2015年5月~2016年1月我院收治的68例HSK炎患者作为观察对象,纳入标准:①符合HSK相关临床诊断标准[2],且经病原学确诊为HSV感染;②……

登录APP查看全文